Sponsor	NOVARTIS
Subject	VEGF inhibition in RVO: clinical experience to recommendation
Time	12:40-13:40
Venue	Room 13
Chairs	Jong Woo KIM Sherman O. VALERO
Speakers	Tatsuro ISHIBASHI Kyu Hyung PARK
Synopsis	RVO background and impact on QoL, Long term data on VEGF inhibition and develop rationale for recommendation